These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16783994)

  • 41. Polypill: for Pollyanna.
    Spence JD
    Int J Stroke; 2008 May; 3(2):92-7. PubMed ID: 18706002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cardiovascular disease in those aged 55 years and over controlled with a combined pill against 4 risk factors: some brief comments].
    Rabelink TJ
    Ned Tijdschr Geneeskd; 2003 Aug; 147(32):1537-8. PubMed ID: 12942841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling study.
    Marshall T
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):523-8. PubMed ID: 16874140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polypill in cardiovascular disease: has it's time come?
    Kuppuswamy V; Choo WK; Gupta S
    Indian Heart J; 2009; 61(4):322-7. PubMed ID: 20635733
    [No Abstract]   [Full Text] [Related]  

  • 45. Polypill for Population-Level Primary Cardiovascular Prevention in Underserved Populations-A Social Epidemiology Counterargument.
    Cainzos-Achirica M; Bilal U
    Am J Med; 2020 Oct; 133(10):e541-e543. PubMed ID: 32442515
    [No Abstract]   [Full Text] [Related]  

  • 46. The Effect of a Cardiovascular Polypill Strategy on Pill Burden.
    Truelove M; Patel A; Bompoint S; Brown A; Cass A; Hillis GS; Peiris D; Rafter N; Reid CM; Rodgers A; Tonkin A; Usherwood T; Webster R;
    Cardiovasc Ther; 2015 Dec; 33(6):347-52. PubMed ID: 26280247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?
    Rastegarpanah M; Malekzadeh F; Thomas GN; Mohagheghi A; Cheng KK; Marshall T
    Arch Iran Med; 2008 May; 11(3):306-13. PubMed ID: 18426322
    [No Abstract]   [Full Text] [Related]  

  • 48. Polypill: Can its Potential Enhancement of Efficacy Trigger New Interest?
    Chao J; Bansilal S
    Glob Heart; 2016 Dec; 11(4):469-472. PubMed ID: 27938845
    [No Abstract]   [Full Text] [Related]  

  • 49. What's new in type 2 diabetes?
    McCarthy JC; Pearson RD
    J Fam Pract; 2012 Nov; 61(11):646-51. PubMed ID: 23256094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The polypill: at what price would it become cost effective?
    Franco OH; Steyerberg EW; de Laet C
    J Epidemiol Community Health; 2006 Mar; 60(3):213-7. PubMed ID: 16476750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Differentiated treatment of diabetics with an acute coronary syndrome].
    Hamm CW; Hamann A
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
    [No Abstract]   [Full Text] [Related]  

  • 52. A single pill for prevention?
    Harv Heart Lett; 2009 Jul; 19(11):6. PubMed ID: 19927382
    [No Abstract]   [Full Text] [Related]  

  • 53. Strengths and Limitations of Using the Polypill in Cardiovascular Prevention.
    Roy A; Naik N; Srinath Reddy K
    Curr Cardiol Rep; 2017 May; 19(5):45. PubMed ID: 28425033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A strategy to reduce cardiovascular disease by more than 80%.
    Wald NJ; Law MR
    BMJ; 2003 Jun; 326(7404):1419. PubMed ID: 12829553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementation of a simple age-based strategy in the prevention of cardiovascular disease: the Polypill approach.
    Wald DS; Wald NJ
    J Eval Clin Pract; 2012 Jun; 18(3):612-5. PubMed ID: 21276141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving cardiovascular protection: focus on a cardiovascular polypill.
    Barrios V; Escobar C
    Future Cardiol; 2016 Mar; 12(2):181-96. PubMed ID: 26652213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treating many conditions--with just one pill. The polypill could make your medicines much easier to take.
    Harv Womens Health Watch; 2012 Dec; 20(4):5. PubMed ID: 23346615
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Meggison H
    Clin Evid; 2004 Jun; (11):777-806. PubMed ID: 15652037
    [No Abstract]   [Full Text] [Related]  

  • 59. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.
    Sirois C; Moisan J; Poirier P; Grégoire JP
    Diabetes Care; 2007 Jul; 30(7):1880-2. PubMed ID: 17384345
    [No Abstract]   [Full Text] [Related]  

  • 60. Statin therapy in patients with type 2 diabetes.
    Lo V; Noviasky J; Nashelsky J
    Am Fam Physician; 2005 Sep; 72(5):866-8. PubMed ID: 16156346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.